Immunopotentiation with Ubenimex for prevention of leukemia relapse after allogeneic BMT. The Study Group of Ubenimex for BMT

Transplant Proc. 1992 Dec;24(6):3047-8.
No abstract available

Publication types

  • Clinical Trial
  • Randomized Controlled Trial

MeSH terms

  • Adjuvants, Immunologic / administration & dosage*
  • Administration, Oral
  • Adolescent
  • Adult
  • Bone Marrow Transplantation / immunology*
  • Child
  • Child, Preschool
  • Chronic Disease
  • Female
  • Graft vs Host Disease / immunology
  • Graft vs Host Reaction / immunology*
  • Humans
  • Infant
  • Leucine / administration & dosage
  • Leucine / analogs & derivatives*
  • Leukemia, Myelogenous, Chronic, BCR-ABL Positive / immunology
  • Leukemia, Myelogenous, Chronic, BCR-ABL Positive / surgery*
  • Leukemia, Myeloid, Acute / immunology
  • Leukemia, Myeloid, Acute / surgery*
  • Male
  • Recurrence

Substances

  • Adjuvants, Immunologic
  • Leucine
  • ubenimex